WeVote
Log In

Bill

Bill

HB 1464

Relating to a prescription drug purchasing pool for certain health benefit plan issuers and employers.

89th Legislature (2025) Introduced by James Talarico

Texas bill creates collective drug-purchasing pool for insurers and employers to negotiate lower prescription prices through combined bargaining power.

Committee report sent to Calendars
#comptrollerofpublicaccounts(v2608) #employeebenefits&leave(s0452) #health&humanservicescommission(v0177) #health--general(i0385) #insurance--health&accident(i0422) #insurance--insurers&agents(i0425) #medicine&prescriptiondrugs(s7338)
0
WeVote Research Nonpartisan
Bill Summary · HB 1464

Legislative bill overview

HB 1464 establishes a prescription drug purchasing pool that allows health benefit plan issuers and employers to collectively negotiate drug prices through a shared purchasing mechanism. This pooling arrangement is designed to increase bargaining power when purchasing medications for their covered populations. The bill creates a framework for these entities to coordinate their purchasing decisions to potentially reduce costs.

Why is this important

Prescription drug costs represent a significant expense for health insurers and self-insured employers, which is ultimately passed to consumers through premiums and out-of-pocket costs. By enabling collective purchasing, the bill aims to leverage group negotiating power similar to how large pharmacy benefit managers operate. This could theoretically reduce drug prices and make medications more affordable for Texans, though actual savings depend on implementation and market participation.

Potential points of contention

  • Antitrust concerns: Competitors pooling purchasing power could raise questions about whether collective negotiations violate antitrust laws or constitute illegal price-fixing, though purchasing cooperatives generally have legal protections
  • Pharmacy benefit manager impact: Existing PBMs and pharmaceutical manufacturers may oppose this as it could disrupt current drug distribution and pricing arrangements they control
  • Participation and viability: Without sufficient voluntary participation from insurers and employers, the pool may lack sufficient scale to achieve meaningful negotiating leverage against drug manufacturers

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.